
Synthon: Benelux Deal of the Year – Real Deals
We are proud to share that BC Partners has been named winner of the ‘Benelux Deal of the Year’ award…
Discover our latest insights and keep up to date with BC Partners’ news.

We are proud to share that BC Partners has been named winner of the ‘Benelux Deal of the Year’ award…
At the start of this year, BC Partners, alongside Bpifrance, completed the acquisition of Biogaran – a major player in…
IGS GeboJagema is the leading independent healthcare manufacturer in the tooling market for medical devices — and one of…

BC Partners’ Chairman of Europe Nikos Stathopoulos says there’s a lot of opportunity to invest in Europe and make good…

In a new series shining a light on BC Partners’ approach to operational excellence, we’re sitting down with members of…

In this macro-commentary from the BC Partners’ Credit team, Ted Goldthorpe and Mike Terwilliger, CFA, examine the current risks posed…

In a recent Financial Times article, BC Partners’ Alexis Maskell comments on the attractiveness of the European buyout market, with…

As part of BC Partners’ latest series focused on operational excellence, we’re sitting down with members of our Portfolio Operations…

Apollo Global Management Inc. and BC Partners agreed to acquire a controlling stake in GFL Environmental Inc.’s environmental services unit,…

GFL Environmental Inc. (NYSE: GFL) (TSX: GFL) (“GFL” or the “Company”) today announced that it has entered into a definitive…

Find out more about BC Partners’ investment in IMA, a global leader in the design and manufacture of automatic packaging…

Goldman Sachs Asset Management has agreed a more than €2bn deal to acquire drugmaker Synthon from BC Partners, according to…